Press Releases

Press Release

Cardiol Therapeutics Announces First Patient Enrolled in ARCHER, a Phase II Clinical Trial of CardiolRx™ for Treatment of Acute Myocarditis

August 03, 2022

Press Release

Cardiol Therapeutics Reports Results of 2022 Annual General Meeting

June 29, 2022

Press Release

Cardiol Therapeutics to Webcast Virtual Annual General Meeting on June 28th at 4:30 p.m. EDT

June 27, 2022

Press Release

Cardiol Therapeutics Announces At-The-Market Equity Offering Program

June 09, 2022

Press Release

Cardiol Therapeutics Appoints Teri Loxam and Chris Waddick to its Board of Directors

May 19, 2022

Press Release

Cardiol Therapeutics Announces FDA Investigational New Drug Application (IND) Authorization for Multicenter Phase II Open-label Pilot Study of CardiolRx™ for Recurrent Pericarditis

May 17, 2022

Press Release

Cardiol Therapeutics Announces Year-End 2021 Update on Operations

March 24, 2022

Press Release

Cardiol Therapeutics to Participate in Cantor Fitzgerald’s Virtual Rare Orphan Disease Summit

March 22, 2022

Press Release

Cardiol Therapeutics Appoints Jennifer M. Chao to its Board of Directors

March 15, 2022